- Home
- CCLD vs ARTV Comparison
CCLD vs ARTV Comparison
Compare CCLD & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCLD
- ARTV
- Stock Information
- Founded
- CCLD 1999
- ARTV 2019
- Country
- CCLD United States
- ARTV United States
- Employees
- CCLD N/A
- ARTV N/A
- Industry
- CCLD Computer Software: Prepackaged Software
- ARTV
- Sector
- CCLD Technology
- ARTV
- Exchange
- CCLD Nasdaq
- ARTV NYSE
- Market Cap
- CCLD 52.5M
- ARTV 61.9M
- IPO Year
- CCLD 2014
- ARTV 2024
- Fundamental
- Price
- CCLD $1.91
- ARTV $2.08
- Analyst Decision
- CCLD Buy
- ARTV Strong Buy
- Analyst Count
- CCLD 2
- ARTV 7
- Target Price
- CCLD $3.00
- ARTV $20.00
- AVG Volume (30 Days)
- CCLD 689.0K
- ARTV 212.7K
- Earning Date
- CCLD 05-06-2025
- ARTV 05-08-2025
- Dividend Yield
- CCLD N/A
- ARTV N/A
- EPS Growth
- CCLD N/A
- ARTV N/A
- EPS
- CCLD N/A
- ARTV N/A
- Revenue
- CCLD $112,507,000.00
- ARTV N/A
- Revenue This Year
- CCLD $3.18
- ARTV N/A
- Revenue Next Year
- CCLD $5.81
- ARTV N/A
- P/E Ratio
- CCLD N/A
- ARTV N/A
- Revenue Growth
- CCLD N/A
- ARTV N/A
- 52 Week Low
- CCLD $1.04
- ARTV $1.78
- 52 Week High
- CCLD $4.84
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- CCLD 56.01
- ARTV N/A
- Support Level
- CCLD $1.73
- ARTV N/A
- Resistance Level
- CCLD $2.44
- ARTV N/A
- Average True Range (ATR)
- CCLD 0.18
- ARTV 0.00
- MACD
- CCLD 0.05
- ARTV 0.00
- Stochastic Oscillator
- CCLD 50.00
- ARTV 0.00
About CCLD CareCloud Inc.
CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).